University Hospital Toulouse
Toulouse, 31000, France
Location status: Recruiting
NCT Number: NCT04848025
Airway stenting is usually efficient to treat central airway obstruction but can lead to severe and potentially lethal complications (stent migration, obstructive granuloma, perforation, and hemoptysis).
3D customized airway stents (computer-aided conception using CT-scan data), perfectly suited to airway anatomy, should improve the tolerance and safety of airway stenting.
We demonstrated in a previous pilot study, dedicated to patients with anatomically complex stenoses the safety of 3D patient-specific stents. These appealing results in highly complex situations suggest the need to evaluate these devices in more common situations.
In this study we aim to test our new generation stents in all patients planned for airway stenting. After computer-assisted segmentation of airways (VGStudioMAX 3.0 software), the stenosis is virtually corrected, leading to the conception of a virtual stent (AnatomikModeling, Toulouse), allowing for the fabrication of a mold using a 3D printer. The stent is then built and sterilized (NOVATECH, Berlin) and inserted during rigid bronchoscopy.
Close follow up is then conducted, including clinical evaluation after one week, three, six and 12 months; spirometry at one week, 3 months, 6 months and 12 months and chest CT-scan at one week.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Toulouse, 31000, France
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Computer-assisted segmentation of airways and stent from CT data (AnatomikModeling) Fabrication of a mold and then a silicon stent by mold injection and sterilization (NOVATECH) Insertion of the stent under rigid bronchoscopy and general anesthesia
Time frame: 12 months
Percentage of procedures with clinical improvement of the dyspnea with questionnaires of Borg, modified Medical Research Council (mMRC), and Dyspnea 12
Time frame: 12 months
Percentage of procedures with clinical improvement of quality of life with the VQ11 questionnaire
Time frame: 1 seconde
Percentage of procedures with functional improvement ( forced expiratory volume in one second (FEV1))
Time frame: 1 week
Percentage of procedures with congruence of the stent with tracheobronchial anatomy on CT-scan at 1 week
Time frame: 12 months
Percentage of procedures without complications at 1 week, 3 months, 6 months and 12 months (stent migration, obstructive granuloma, perforation, hemoptysis).
Time frame: 12 months
Percentage of procedures with clinical (dyspnea, cough, quality of life (VQ11 questionnaire)), and functional improvement (peak flow, forced expiratory volume in one second (FEV1)) at 3 months, 6 months and 12 months
Contact information is provided by the study sponsor or research team.
University Hospital, Toulouse
Other
Treatment of Central Airway Stenoses Using Computer-Assisted Customized 3d Stents TATUM (Three-dimensional Airway Tailored Stent Using Computer-aided Modeling)
Acronym: TATUM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06144476
Airway Disease, Asthma
London, United Kingdom
View Trial DetailsNCT06503016
Airway Disease, Arrhythmias, Cardiac
Milan, Italy
View Trial DetailsNCT07065565
Airway Disease, Respiratory Tract Diseases
Guangdong, Gaungzhou, China
View Trial DetailsNCT05976919
Airway Disease
Leeds, United Kingdom
View Trial Details